Immediate Impact
50 standout
Citing Papers
Drug resistance in ovarian cancer: from mechanism to clinical trial
2024 Standout
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
2024 Standout
Works of Yoichi Kase being referenced
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer
2021
Phase 1 study of ixazomib alone or combined with lenalidomide-dexamethasone in Japanese patients with relapsed/refractory multiple myeloma
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Yoichi Kase | 45 | 29 | 20 | 39 | 35 | 22 | 212 | |
| Yingxin Yang | 64 | 25 | 19 | 15 | 35 | 23 | 298 | |
| Vicente Moreno | 24 | 32 | 79 | 60 | 64 | 23 | 293 | |
| Martina Antošová | 56 | 13 | 13 | 10 | 23 | 29 | 293 | |
| Erika Sugiyama | 37 | 14 | 82 | 89 | 45 | 26 | 269 | |
| Andrew Wilson | 13 | 7 | 27 | 14 | 29 | 36 | 153 | |
| Jiahai Ma | 110 | 13 | 28 | 14 | 62 | 24 | 257 | |
| Shui Yu | 57 | 17 | 19 | 15 | 37 | 22 | 259 | |
| Laura Sottosanti | 17 | 19 | 23 | 52 | 6 | 19 | 258 | |
| Amarjit Cheema | 39 | 8 | 9 | 16 | 24 | 18 | 276 | |
| Ka Lam Wong | 95 | 15 | 46 | 16 | 35 | 21 | 298 |
All Works
Login with ORCID to disown or claim papers
Loading papers...